
Craig D. Ricci
Examiner (ID: 6907, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1601 |
| Issued Applications | 776 |
| Pending Applications | 153 |
| Abandoned Applications | 697 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19904127
[patent_doc_number] => 12281123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Benzoxazinone compounds as KLK5/7 dual inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/295009
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16902
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295009
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295009 | Benzoxazinone compounds as KLK5/7 dual inhibitors | Apr 2, 2023 | Issued |
Array
(
[id] => 18674956
[patent_doc_number] => 20230312473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => PROCESS FOR THE PREPARATION OF BIHETEROARYL COMPOUNDS AND CRYSTAL FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/194423
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194423
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/194423 | PROCESS FOR THE PREPARATION OF BIHETEROARYL COMPOUNDS AND CRYSTAL FORMS THEREOF | Mar 30, 2023 | Pending |
Array
(
[id] => 19938944
[patent_doc_number] => 12311058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Single protein-encapsulated pharmaceutics for enhancing therapeutic effects
[patent_app_type] => utility
[patent_app_number] => 18/128828
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 6679
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128828
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128828 | Single protein-encapsulated pharmaceutics for enhancing therapeutic effects | Mar 29, 2023 | Issued |
Array
(
[id] => 20286484
[patent_doc_number] => 20250311727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => SUBSTITUTED 2-AMINOAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 18/849793
[patent_app_country] => US
[patent_app_date] => 2023-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18849793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/849793 | SUBSTITUTED 2-AMINOAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | Mar 22, 2023 | Pending |
Array
(
[id] => 20187003
[patent_doc_number] => 12398108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Compounds, compositions, and methods for treating diseases
[patent_app_type] => utility
[patent_app_number] => 18/120757
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6355
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120757
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120757 | Compounds, compositions, and methods for treating diseases | Mar 12, 2023 | Issued |
Array
(
[id] => 19884111
[patent_doc_number] => 12269803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease
[patent_app_type] => utility
[patent_app_number] => 18/116593
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 53
[patent_no_of_words] => 45640
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116593
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/116593 | Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease | Mar 1, 2023 | Issued |
Array
(
[id] => 20040805
[patent_doc_number] => 20250179027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => CYCLOALKYL OR HETEROCYCLYL SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/843672
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18843672
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/843672 | CYCLOALKYL OR HETEROCYCLYL SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND USE THEREOF | Mar 1, 2023 | Pending |
Array
(
[id] => 18552099
[patent_doc_number] => 20230250105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
[patent_app_type] => utility
[patent_app_number] => 18/175030
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175030 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity | Feb 26, 2023 | Abandoned |
Array
(
[id] => 20808940
[patent_doc_number] => 20260183756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-07-02
[patent_title] => CATALYST, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING ACRYLONITRILE
[patent_app_type] => utility
[patent_app_number] => 18/837343
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18837343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/837343 | CATALYST, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING ACRYLONITRILE | Feb 21, 2023 | Pending |
Array
(
[id] => 19638048
[patent_doc_number] => 12168648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Opioid receptor modulators
[patent_app_type] => utility
[patent_app_number] => 18/168155
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168155 | Opioid receptor modulators | Feb 12, 2023 | Issued |
Array
(
[id] => 18893856
[patent_doc_number] => 20240009341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => DRESSING, A KIT COMPRISING A DRESSING AND A METHOD OF PREPARING A DRESSING
[patent_app_type] => utility
[patent_app_number] => 18/108443
[patent_app_country] => US
[patent_app_date] => 2023-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18108443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/108443 | DRESSING, A KIT COMPRISING A DRESSING AND A METHOD OF PREPARING A DRESSING | Feb 9, 2023 | Pending |
Array
(
[id] => 19889063
[patent_doc_number] => 20250114375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => PHARMACEUTICAL COMPOSITION OF LIFITEGRAST AND LOTEPREDNOL ETABONATE
[patent_app_type] => utility
[patent_app_number] => 18/836057
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18836057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/836057 | PHARMACEUTICAL COMPOSITION OF LIFITEGRAST AND LOTEPREDNOL ETABONATE | Feb 7, 2023 | Pending |
Array
(
[id] => 20033204
[patent_doc_number] => 20250171426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => PYRIMIDINEDIONE-BASED COMPOUNDS AS AXL, C-MET, AND MER INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/839273
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 619
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18839273
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/839273 | PYRIMIDINEDIONE-BASED COMPOUNDS AS AXL, C-MET, AND MER INHIBITORS AND METHODS OF USE THEREOF | Jan 30, 2023 | Pending |
Array
(
[id] => 20200394
[patent_doc_number] => 12403159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Therapeutic metal complexes and ligands and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 18/102474
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 12724
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102474 | Therapeutic metal complexes and ligands and methods of making and using the same | Jan 26, 2023 | Issued |
Array
(
[id] => 19846715
[patent_doc_number] => 20250092066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => SUBSTITUTED BICYCLIC HETEROCYCLES AS MALT-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/728362
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18728362
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/728362 | SUBSTITUTED BICYCLIC HETEROCYCLES AS MALT-1 INHIBITORS | Jan 16, 2023 | Pending |
Array
(
[id] => 20808506
[patent_doc_number] => 20260183319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-07-02
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/728162
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18728162
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/728162 | PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND | Jan 11, 2023 | Pending |
Array
(
[id] => 20092024
[patent_doc_number] => 20250221960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/727772
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18727772
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/727772 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION | Jan 8, 2023 | Pending |
Array
(
[id] => 18391347
[patent_doc_number] => 20230159565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Solid Forms of Substituted Benzoxaborole and Compositions Thereof
[patent_app_type] => utility
[patent_app_number] => 18/094502
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094502
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094502 | Solid forms of substituted benzoxaborole and compositions thereof | Jan 8, 2023 | Issued |
Array
(
[id] => 18559757
[patent_doc_number] => 11724991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-15
[patent_title] => Selective 5-LO inhibitors for the treatment of bronchial asthma
[patent_app_type] => utility
[patent_app_number] => 18/094113
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7174
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094113 | Selective 5-LO inhibitors for the treatment of bronchial asthma | Jan 5, 2023 | Issued |
Array
(
[id] => 19983971
[patent_doc_number] => 20250122193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/721989
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721989 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | Dec 21, 2022 | Pending |